Attendees will learn the basic principles of low-dose buprenorphine induction, including indications, pharmacology, and dosing.
- Implement low-dose buprenorphine induction as an option for individuals using illicit fentanyl or long-acting opioids
- Appreciate limitations and cautions of low-dose induction.
- Clarify low-dose buprenorphine induction protocols in various practice settings
WHO SHOULD ATTEND
This presentation was developed for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators.
Joshua Blum, MD
Dr. Blum is a board-certified internist and addiction medicine physician at Denver Health and Hospital Authority in Denver, CO. He currently serves as the director of adult outpatient addiction treatment services. He is an institutional quality officer and leads initiatives on pain and opioid management, including inpatient and outpatient guidelines, order sets, naloxone co-prescription, and the expansion of opioid use disorder treatment in Denver Health’s primary care clinics. He is the current Colorado chapter president of the American Society of Addiction Medicine, and co-chair of the Provider Education Workgroup at the Colorado Consortium for Prescription Drug Abuse Prevention. He serves on the boards of the Colorado Pain Society, the Denver Medical Society, and the Harm Reduction Action Center. Dr. Blum specializes in caring for high-risk populations, including incarcerated individuals and people with HIV. He lectures locally and regionally on HIV and Hepatitis C, chronic pain syndromes, opioid management, and substance use disorders. Dr. Blum attended Dartmouth College and the University of Southern California School of Medicine before completing his medicine residency at the University of Colorado.
This course has been approved by the California Board of Registered Nursing for a maximum of 1.00 Nursing Contact Hour. The licensee must retain this document for a period of four (4) years after the course concludes.